News

New Therapeutic Option to Reduce Risk of Cardiovascular Deaths and Repeated Hospitalisations Among Adult Heart Failure Patients Approved in Singapore

Bayer's VERQUVO™ (vericiguat), a soluble guanylate cyclase (sGC) stimulator, has been approved in Singapore for the treatment of symptomatic chronic...